Search for: "Life Ins. Co. of Georgia v. Johnson" Results 1 - 9 of 9
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 May 2019, 9:27 am by MOTP
Rather, he stated that the factors relevant to his attorney's fees were (1) the amount in controversy, (2) the complexity of the case, and (3) his knowledge and experience—three of the eight factors set out in Arthur Andersen & Co. v. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) –… [read post]
10 Mar 2008, 1:10 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993); General Electric Co. v. [read post]